Results 241 to 250 of about 130,679 (320)

Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database. [PDF]

Brain Sci
Chiappini S, Orsolini L, Corkery JM, Guirguis A, Mosca A, Arillotta D, Martinotti G, Schifano F.   +7 more
europepmc   +1 more source

Substance Use Patterns and Negative Urine Opioid Screen Among Patients on Methadone Treatment at a Referral Hospital in Nairobi, Kenya. [PDF]

Susan Wangeci Kuria
openalex   +1 more source

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

The American Journal on Addictions, Volume 35, Issue 1, Page 46-52, January 2026.
Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik, Tyler Lister, Ainhoa Gomez‐Lumbreras, Randall T. Peterson, Marco Bortolato, Daniel C. Malone   +5 more
wiley   +1 more source

Mobile addiction treatment units: a narrative review. [PDF]

Addict Sci Clin Pract
Barrera I, Wang G, Rajakumar B, Muthupalaniappan S, Cronin AE, Chatterjee A.   +5 more
europepmc   +1 more source

A Community-Based Evaluation of Sudden Death Associated with Therapeutic Levels of Methadone

, 2008
Sumeet S. Chugh, Carmen Socoteanu, Kyndaron Reinier, Justin Waltz, Jonathan Jui, Karen Gunson   +5 more
openalex   +1 more source

Methadone for neuropathic pain in adults.

Cochrane Database of Systematic Reviews, 2017
E. McNicol, McKenzie C. Ferguson, R. Schumann   +2 more
semanticscholar   +1 more source

Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study

The American Journal on Addictions, Volume 35, Issue 1, Page 90-93, January 2026.
Abstract Background and Objectives There are hardly any data from longitudinal studies on the prevalence of mental health disorders in patients in opioid agonist therapy (OAT). Methods Here we report prevalence rates of mental health disorders in a 6‐year naturalistic noninterventional follow‐up study of patients in OAT (N = 2694 at baseline).
Michael Soyka, Gabi Koller, Wittchen Hans‐Ulrich, Gerhard Bühringer   +3 more
wiley   +1 more source

How Did Medicaid's 1115 Substance Use Disorder Waivers Increase Medication Treatment for Opioid Use Disorder? Evidence From Eight Waiver States. [PDF]

Milbank Q
Lindner SR, Hall J, Manibusan B, Byers J, Hart K, Baron A, McCARTY D, McCONNELL KJ, Cohen DJ.   +8 more
europepmc   +1 more source

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

, 2017
Maurice Demattéis, Marc Auriacombe, Oscar D’Agnone, Lorenzo Somaini, Néstor Szerman, Richard Littlewood, Farrukh Alam, Hannu Alho, Amine Benyamina, Julio Bobes, Jean Pierre Daulouede, Claudio Leonardi, Icro Maremmani, Marta Torrens, Stephan Walcher, Michael Soyka   +15 more
openalex   +2 more sources

Management of Neuropathic Chronic Pain with Methadone Combined with Ketamine: A Randomized, Double Blind, Active-Controlled Clinical Trial.

Pain Physician, 2017
F. Rigo, G. Trevisan, M. C. Godoy, M. Rossato, G. D. Dalmolin, M. A. Silva, Mirian S Menezes, W. Caumo, J. Ferreira   +8 more
semanticscholar   +1 more source